Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Technique to Insure Stable Supply of Flu Drug

By Biotechdaily staff writers
Posted on 31 Mar 2006
A team of Japanese researchers has developed a new technique for producing the anti-flu drug Tamiflu (ostelamivir) that does not rely on natural ingredients, which may help ensure a more stable supply of the drug in the event of a pandemic.

Researchers at the University of Tokyo's Graduate School of Pharmaceutical Sciences (Japan) have found a way to manufacture Tamiflu without using shikimic acid, produced from a spice called star anise. More...
This brownish star-shaped fruit of the illicium verum tree is often used as a spice in Chinese cuisine. The new technique, called asymmetric catalysis, produces Tamiflu from a petrochemical ingredient called 1,4-cyclohexadiene instead, eliminating weather as a risk factor in Tamiflu production. Tamiflu, produced by Roche (Basel, Switzerland), is considered one of the best defenses against avian flu in humans.

If things go well, I hope we may be able to pave the way towards giving supplies to society in around two years, said Professor Masakatsu Shibasaki, a biochemist and leader of the team that developed the process, adding that he would soon submit a paper on his team's findings to the Journal of the American Chemical Society. Tokyo University has applied for an intellectual property patent in Japan and is now in discussions with Roche on a number of issues regarding further research and licensing.

Asymmetric catalysis is a chemical-reaction process invented by Professor Ryoji Noyori, now president of the Riken Institute (Saitama, Japan), a multi-site Japanese research initiative with an annual budget of U.S.$800 million. He was awarded the 2001 Nobel Prize in chemistry for his development of the process.



Related Links:
U. of Tokyo Grad. School of Pharmaceutical Sciences

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.